Pardo Ryan sold 587,920 shares of LifeStance Health Group, Inc. at $14.58 for −$8.57M on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
See Remarks
See Remarks
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$8,571,873.60Shares × reported price
Shares traded
587,920Common Stock
Price per share
$14.58Reported price. Read footnotes for ranges.
% of reported position traded
53.77%This security and ownership context
Holdings after
505,446Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 13, 2026, 9:05 PM ET4-day reporting delay
Accession
0001193125-26-461382Code S · Transaction 401518
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,093,366 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell2,216,585$14.58−$32,317,809.30Trade 401519
2 transaction rows in this filing. Joint filers share the same rows.

LFST price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LFST · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 21, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −12%1w ago −7%1d ago −7%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026. F3: Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026. F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5: Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.